UPDATE 3-Clovis's ovarian cancer drug wins accelerated FDA approval

* Shares soar as much as 26 pct (Adds Lynparza sales and Rubraca sales estimate) [Source]

Publication Date: Monday, 19 December 2016 at 21:47:14

Origin: reuters.com

Category: hotStocksNews

Topics: sales, estimate), Rubraca, Lynparza, (Adds, Shares, approval, accelerated, cancer, ovarian, 3-Clovis's, UPDATE

Source: http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/pGmoHVaHvPA/clovis-oncology-fda-idUSL4N1EE481

Related Articles

UPDATE 1-Ferrari races to new high after earnings top forecast

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:48:11

UPDATE 2-Ralph Lauren CEO to leave after differences with founder

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:24:14

UPDATE 1-Sterling, gilt yields skid as BoE seems in no rush to raise rates

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 16:03:29

UPDATE 2-Fingerprint Cards suffers fresh setback with weak outlook

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 14:30:03

UPDATE 3-Daimler pursues new records in tougher environment

[ reuters.com ] hotStocksNews, Thursday, 2 February 2017 at 14:27:59